A single high dose of idarubicin combined with high-dose ARA-C (MSKCC all-3 protocol) in adult and pediatric patients with acute lymphoblastic leukemia. Experience at the University 'La Sapienza' of Rome

Haematologica

Volumn 82, Issue 6, 1997, Pages 664-667

  Testi, Anna Maria ^a,b   Moleti, Maria Luisa ^a   Giona, Fiorina ^a   Annino, Luciana ^a   Chiaretti, Sabina ^a   Del Giudice, Ilaria ^a   Todisco, Elisabetta ^a   D'Elia, Giannamaria ^a   Ferrari, Antonella ^a   Arcese, William ^a   Mandelli, Franco ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b Dipto Biotecnologie Cellulari ed E   (Italy)

Author keywords

Acute lymphoblastic leukemia; Chemotherapy; Cytosine arabinoside; Idarubicin; Relapse

Indexed keywords

ASPARAGINASE; CYCLOPHOSPHAMIDE; CYTARABINE; ETOPOSIDE; HYDROXYUREA; IDARUBICIN; MERCAPTOPURINE; METHOTREXATE; PREDNISONE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CARDIOTOXICITY; CHILD; CLINICAL TRIAL; CONJUNCTIVITIS; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; DRUG MEGADOSE; DRUG TOLERABILITY; FEMALE; HUMAN; INFANT; INTRATHECAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; NEPHROTOXICITY; NEUROTOXICITY; PHOTOPHOBIA; PRESCHOOL CHILD; SCHOOL CHILD; SUBCUTANEOUS DRUG ADMINISTRATION;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHILD, PRESCHOOL; CYTARABINE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; IDARUBICIN; INFANT; LEUKEMIA, LYMPHOCYTIC, ACUTE, L1; LEUKEMIA, LYMPHOCYTIC, ACUTE, L2; MALE; ROME;

EID: 0031468398     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Giona F, Testi AM, Amadori S, et al. Idarubicin and high-dose cytarabine in the treatment of refractory and relapsed acute lymphoblastic leukemia. Ann Oncol 1990; 1:51-5.
2. Giona F, Testi AM, Annino L, et al. Treatment of primary refractory and relapsed acute lymphoblastic leukemia in children and adults: the GIMEMA, AIEOP experience. Br J Haematol 1994; 86:55-61.
3. Berman E, Raymond V, Gee T, et al. Idarubicin in acute leukemia: results of studies at Memorial Sloan Kettering Cancer Center. Semin Oncol 1989; 16(suppl. 2):30-4.
4. Weiss M, Maslak P, Megherian L, Scheinberg D. A phase I trial of a single high dose of idarubicin combined with high dose cytarabine (ARA-C) as induction therapy in relapsed and refractory adult patients with acute lymphoblastic leukemia (ALL). Blood 1995; 86 (suppl. 1):786a.
5. World Health Organization. WHO handbook for reporting results of cancer treatment. Geneva: WHO Publication 1979:38.
6. Ohnuma T, Rosner F, Levy RN, et al. Treatment of adult leukemia with L-asparaginase. Cancer Chemother Rep 1971; 55:269-75.
7. Yates J, Glidewell O, Wiernik P, et al. Cytosine arabinoside with daunorubicin or adriamicin for therapy of acute myelocytic leukemia: a CALGB study. Blood 1982; 60:454-9.
8. Conter V, Rizzari C, Aricò M, et al. Preliminary results of the AIEOP 1991 study for childhood acute lymphoblastic leukemia (ALL). Med Pediatr Oncol 1995; 25:283.
9. Henze G, Fengler R, Hartmann R, et al. Six-year experience with a comprehensive approach to the treatment of recurrent childhood acute lymphoblastic leukemia (ALL-REZ BFM85). A relapse study of the BFM group. Blood 1991; 78:1166-72.
10. Annino L, for the GIMEMA cooperative group. GIMEMA multicentric trial for treatment of acute lymphoblastic leukemia in adults (ALL 0288). Interim report. Blood 1992; 80(suppl. 1):28.
11. Amadori S, Annino L, Ferrari A, et al. Therapy of adult acute lymphoblastic leukemia. Preliminary results of the GIMEMA ALL 0288 study. In: R Buckner et al., eds. Acute leukemia IV. Berlin: Springer Verlag; 1994. p. 432-6.
12. Annino L, Ferrari A, Del Poeta G, et al. Myeloid-like induction for adult acute lymphoblastic leukemia (ALL). The GIMEMA ALL 0394 pilot study. Proc XIIth Meeting International Society of Hematology, Istanbul, Turkiye, September 7-8, 1995.
13. Arcese W, Amadori S, Meloni G, et al. Allogeneic and autologous bone marrow transplantation for intensification of salvage therapy in patients with high risk advanced acute lymphoblastic leukemia. Semin Hematol 1991; 28:116-21.
14. Bassan R, Lerede T, Rambaldi A, Buelli M, Viero P, Barbui T. The use of anthracyclines in adult acute lymphoblastic leukemia. Haematologica 1995; 80:280-91.
15. Lerede T, Bassan R, Rossi A, et al. Therapeutic impact of adult-type acute lymphoblastic leukemia regimens in B-cell/L3 acute leukemia and advanced-stage Burkitt's lymphoma. Haematologica 1996; 81:442-9.